StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · BSEM·Healthcare

BioStem Technologies, Inc. Stock Analysis & AI Score

BioStem Technologies, Inc. (BSEM) has an ST Score of 37.7 (C), driven by its Forecast (A-) and held back by its Financial Strength (F). BSEM last traded at $3.88.

Market Closed
$3.88
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
38
ST Score
37.7/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryBiotechnology
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

BSEM
37.7out of 100
Grade C

BioStem Technologies, Inc. (BSEM) has an ST Score of 37.7 (C), driven by its Forecast (A-) and held back by its Financial Strength (F). BSEM last traded at $3.88.

Strongest
ForecastA-
Weakest
Financial StrengthF
All factor grades
  • ForecastA-
  • ValuationB-
  • MomentumB-
  • GrowthC-
  • ProfitabilityD+
  • Financial StrengthF
  • Piotroski2/9
Score methodology
Press Releases

Contact

BSEM stock: frequently asked questions

What is BSEM's ST Score?

BioStem Technologies, Inc. (BSEM) has an ST Score of 37.7 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is BSEM a buy, hold, or sell?

Our ST Score grades it C (37.7/100). The ST Score is a data-driven signal, not a recommendation.

What are BSEM's factor grades?

Valuation B-, Profitability D+, Financial Strength F, Momentum B-, Growth C-, Forecast A-.

What is BSEM's valuation grade?

BioStem Technologies, Inc. (BSEM) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is BSEM's growth grade?

BioStem Technologies, Inc. (BSEM) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is BSEM's profitability grade?

BioStem Technologies, Inc. (BSEM) earns a profitability grade of D+, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is BSEM's financial strength grade?

BioStem Technologies, Inc. (BSEM) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for BSEM?

The average analyst price target for BioStem Technologies, Inc. (BSEM) is $7.00, which is +80.4% versus the recent price of $3.88.

What is BSEM's Piotroski score?

BioStem Technologies, Inc. (BSEM) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.